Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose dexmedetomidine plus esketamine in cesarean section
ChiCTR2400088820Phase 4Completed
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in None comparing Esketamine group with Dexmedetomidine + esketamine group (2 arms). Primary endpoint: Neuropsychiatric symptoms associated with esketamine. Started Sep 2024; status: completed.
02
Drugs
dexmedetomidineesketamine
Beyond the preview
Go deeper on ChiCTR2400088820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088820.